| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $5.4B | $3.0B | $4.4B | $8.8B | $1.5B | $0.5B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $1.0B | $-0.6B | $1.2B | $3.0B | $0.3B | $-0.0B | $-0.0B |
| EPS (Basic) | $2.25 | $2.85 | $-1.68 | $3.39 | $8.37 | $1.47 | $-0.07 | $-0.15 |
| EPS (Diluted) | $2.18 | $2.77 | $-1.68 | $3.35 | $8.20 | $1.44 | $-0.08 | $-0.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.1B | $23.1B | $21.2B | $21.4B | $21.3B | $15.6B | $13.8B | $12.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.0B | $1.3B | $1.4B | $1.4B | $2.5B | $1.0B | $0.8B | $0.6B |
| Total Liabilities | $22.1B | $16.8B | $15.4B | $14.6B | $15.5B | $12.7B | $10.8B | $10.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-3.3B | $-0.8B | $0.2B | $-0.4B | $1.8B | $-0.2B | $0.4B | $-0.3B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.0B | $-0.8B | $-0.0B | $-0.1B | $-0.0B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Financing Cash Flow | $4.0B | $0.7B | $-0.1B | $0.1B | $-0.2B | $0.4B | $-0.1B | $0.1B |